HEADER HYDROLASE 13-NOV-18 6I5G TITLE X-RAY STRUCTURE OF HUMAN SOLUBLE EPOXIDE HYDROLASE C-TERMINAL DOMAIN TITLE 2 (HSEH CTD)IN COMPLEX WITH 15D-PGJ2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BIFUNCTIONAL EPOXIDE HYDROLASE 2; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.3.2.10,3.1.3.76; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EPHX2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HSEH CTD, APOPROTEIN, ALPHA_BETA HYDROLASE FOLD, 15D-PGJ2, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR G.ABIS,J.KOPEC,W.W.YUE,M.R.CONTE REVDAT 3 24-JAN-24 6I5G 1 REMARK REVDAT 2 05-JUN-19 6I5G 1 JRNL REVDAT 1 29-MAY-19 6I5G 0 JRNL AUTH G.ABIS,R.L.CHARLES,J.KOPEC,W.W.YUE,R.A.ATKINSON,T.T.T.BUI, JRNL AUTH 2 S.LYNHAM,S.POPOVA,Y.B.SUN,F.FRATERNALI,P.EATON,M.R.CONTE JRNL TITL 15-DEOXY-DELTA12,14-PROSTAGLANDIN J2INHIBITS HUMAN SOLUBLE JRNL TITL 2 EPOXIDE HYDROLASE BY A DUAL ORTHOSTERIC AND ALLOSTERIC JRNL TITL 3 MECHANISM. JRNL REF COMMUN BIOL V. 2 188 2019 JRNL REFN ESSN 2399-3642 JRNL PMID 31123712 JRNL DOI 10.1038/S42003-019-0426-2 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0107 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 71.83 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 46528 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.174 REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2403 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.06 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3173 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.63 REMARK 3 BIN R VALUE (WORKING SET) : 0.2540 REMARK 3 BIN FREE R VALUE SET COUNT : 153 REMARK 3 BIN FREE R VALUE : 0.2770 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5086 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 94 REMARK 3 SOLVENT ATOMS : 226 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.47000 REMARK 3 B22 (A**2) : -2.17000 REMARK 3 B33 (A**2) : 1.35000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.33000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.164 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.151 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.125 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.594 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.940 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5341 ; 0.017 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 5007 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7220 ; 2.062 ; 1.959 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11558 ; 1.212 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 638 ; 7.240 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 244 ;35.197 ;23.934 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 884 ;15.958 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 28 ;15.581 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 745 ; 0.147 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5962 ; 0.010 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1254 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2534 ; 2.769 ; 3.135 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2535 ; 2.768 ; 3.136 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3166 ; 3.910 ; 4.687 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 3167 ; 3.909 ; 4.688 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2807 ; 3.679 ; 3.551 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2808 ; 3.678 ; 3.553 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 4050 ; 5.546 ; 5.155 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 6240 ; 7.349 ;25.585 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 6241 ; 7.349 ;25.594 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6I5G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-NOV-18. REMARK 100 THE DEPOSITION ID IS D_1200012863. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-APR-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97949 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : XIA2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48933 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 71.830 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 4.990 REMARK 200 R MERGE (I) : 0.09600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.70200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: 3ANS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 22.5% PEG 3350, 0.2 M MALIC ACID, PH REMARK 280 7.4, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z+1/2 REMARK 290 4555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 38.57391 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.99600 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 51.90645 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 38.57391 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 39.99600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 51.90645 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 212 REMARK 465 HIS A 213 REMARK 465 HIS A 214 REMARK 465 HIS A 215 REMARK 465 HIS A 216 REMARK 465 HIS A 217 REMARK 465 HIS A 218 REMARK 465 SER A 219 REMARK 465 THR A 220 REMARK 465 GLU A 221 REMARK 465 ASN A 222 REMARK 465 LEU A 223 REMARK 465 TYR A 224 REMARK 465 PHE A 225 REMARK 465 GLN A 226 REMARK 465 GLY A 227 REMARK 465 SER A 228 REMARK 465 SER A 229 REMARK 465 ALA A 546 REMARK 465 ARG A 547 REMARK 465 ASN A 548 REMARK 465 PRO A 549 REMARK 465 PRO A 550 REMARK 465 VAL A 551 REMARK 465 VAL A 552 REMARK 465 SER A 553 REMARK 465 LYS A 554 REMARK 465 MET A 555 REMARK 465 MET B 212 REMARK 465 HIS B 213 REMARK 465 HIS B 214 REMARK 465 HIS B 215 REMARK 465 HIS B 216 REMARK 465 HIS B 217 REMARK 465 HIS B 218 REMARK 465 SER B 219 REMARK 465 THR B 220 REMARK 465 GLU B 221 REMARK 465 ASN B 222 REMARK 465 LEU B 223 REMARK 465 TYR B 224 REMARK 465 PHE B 225 REMARK 465 GLN B 226 REMARK 465 GLY B 227 REMARK 465 SER B 228 REMARK 465 SER B 229 REMARK 465 ALA B 546 REMARK 465 ARG B 547 REMARK 465 ASN B 548 REMARK 465 PRO B 549 REMARK 465 PRO B 550 REMARK 465 VAL B 551 REMARK 465 VAL B 552 REMARK 465 SER B 553 REMARK 465 LYS B 554 REMARK 465 MET B 555 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 230 OG1 CG2 REMARK 470 SER A 231 OG REMARK 470 THR B 230 OG1 CG2 REMARK 470 SER B 231 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR B 466 O HOH B 701 1.92 REMARK 500 OG SER A 432 O HOH A 701 2.02 REMARK 500 O HOH A 706 O HOH A 764 2.15 REMARK 500 O TRP A 510 O HOH A 702 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 275 NE - CZ - NH1 ANGL. DEV. = 3.8 DEGREES REMARK 500 LEU A 428 CB - CG - CD1 ANGL. DEV. = 13.8 DEGREES REMARK 500 ARG A 440 NE - CZ - NH1 ANGL. DEV. = 5.5 DEGREES REMARK 500 ARG A 440 NE - CZ - NH2 ANGL. DEV. = -5.1 DEGREES REMARK 500 LEU B 340 CA - CB - CG ANGL. DEV. = 13.9 DEGREES REMARK 500 ARG B 440 CD - NE - CZ ANGL. DEV. = 8.6 DEGREES REMARK 500 ARG B 440 NE - CZ - NH1 ANGL. DEV. = 7.2 DEGREES REMARK 500 ARG B 440 NE - CZ - NH2 ANGL. DEV. = -8.0 DEGREES REMARK 500 MET B 528 CG - SD - CE ANGL. DEV. = 11.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 231 -169.39 -114.59 REMARK 500 GLU A 269 -143.26 -116.56 REMARK 500 ASP A 335 -126.75 60.05 REMARK 500 ASN A 359 -37.93 75.00 REMARK 500 ASN A 431 58.04 -117.29 REMARK 500 LEU A 499 79.76 -102.88 REMARK 500 HIS A 513 3.90 -64.47 REMARK 500 SER B 231 -157.40 -103.72 REMARK 500 GLU B 269 -143.92 -118.52 REMARK 500 ASP B 335 -124.88 61.94 REMARK 500 ASN B 359 -44.40 79.38 REMARK 500 ASN B 368 -67.48 -102.31 REMARK 500 PRO B 433 151.42 -47.69 REMARK 500 VAL B 498 -61.71 -109.17 REMARK 500 HIS B 513 41.81 -102.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ARG A 247 VAL A 248 -144.72 REMARK 500 MET A 291 ASP A 292 145.39 REMARK 500 MET B 291 ASP B 292 141.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 605 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 606 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PTG A 607 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 605 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 606 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PTG B 607 DBREF 6I5G A 230 555 UNP P34913 HYES_HUMAN 177 502 DBREF 6I5G B 230 555 UNP P34913 HYES_HUMAN 177 502 SEQADV 6I5G MET A 212 UNP P34913 INITIATING METHIONINE SEQADV 6I5G HIS A 213 UNP P34913 EXPRESSION TAG SEQADV 6I5G HIS A 214 UNP P34913 EXPRESSION TAG SEQADV 6I5G HIS A 215 UNP P34913 EXPRESSION TAG SEQADV 6I5G HIS A 216 UNP P34913 EXPRESSION TAG SEQADV 6I5G HIS A 217 UNP P34913 EXPRESSION TAG SEQADV 6I5G HIS A 218 UNP P34913 EXPRESSION TAG SEQADV 6I5G SER A 219 UNP P34913 EXPRESSION TAG SEQADV 6I5G THR A 220 UNP P34913 EXPRESSION TAG SEQADV 6I5G GLU A 221 UNP P34913 EXPRESSION TAG SEQADV 6I5G ASN A 222 UNP P34913 EXPRESSION TAG SEQADV 6I5G LEU A 223 UNP P34913 EXPRESSION TAG SEQADV 6I5G TYR A 224 UNP P34913 EXPRESSION TAG SEQADV 6I5G PHE A 225 UNP P34913 EXPRESSION TAG SEQADV 6I5G GLN A 226 UNP P34913 EXPRESSION TAG SEQADV 6I5G GLY A 227 UNP P34913 EXPRESSION TAG SEQADV 6I5G SER A 228 UNP P34913 EXPRESSION TAG SEQADV 6I5G SER A 229 UNP P34913 EXPRESSION TAG SEQADV 6I5G MET B 212 UNP P34913 INITIATING METHIONINE SEQADV 6I5G HIS B 213 UNP P34913 EXPRESSION TAG SEQADV 6I5G HIS B 214 UNP P34913 EXPRESSION TAG SEQADV 6I5G HIS B 215 UNP P34913 EXPRESSION TAG SEQADV 6I5G HIS B 216 UNP P34913 EXPRESSION TAG SEQADV 6I5G HIS B 217 UNP P34913 EXPRESSION TAG SEQADV 6I5G HIS B 218 UNP P34913 EXPRESSION TAG SEQADV 6I5G SER B 219 UNP P34913 EXPRESSION TAG SEQADV 6I5G THR B 220 UNP P34913 EXPRESSION TAG SEQADV 6I5G GLU B 221 UNP P34913 EXPRESSION TAG SEQADV 6I5G ASN B 222 UNP P34913 EXPRESSION TAG SEQADV 6I5G LEU B 223 UNP P34913 EXPRESSION TAG SEQADV 6I5G TYR B 224 UNP P34913 EXPRESSION TAG SEQADV 6I5G PHE B 225 UNP P34913 EXPRESSION TAG SEQADV 6I5G GLN B 226 UNP P34913 EXPRESSION TAG SEQADV 6I5G GLY B 227 UNP P34913 EXPRESSION TAG SEQADV 6I5G SER B 228 UNP P34913 EXPRESSION TAG SEQADV 6I5G SER B 229 UNP P34913 EXPRESSION TAG SEQRES 1 A 344 MET HIS HIS HIS HIS HIS HIS SER THR GLU ASN LEU TYR SEQRES 2 A 344 PHE GLN GLY SER SER THR SER CYS ASN PRO SER ASP MET SEQRES 3 A 344 SER HIS GLY TYR VAL THR VAL LYS PRO ARG VAL ARG LEU SEQRES 4 A 344 HIS PHE VAL GLU LEU GLY SER GLY PRO ALA VAL CYS LEU SEQRES 5 A 344 CYS HIS GLY PHE PRO GLU SER TRP TYR SER TRP ARG TYR SEQRES 6 A 344 GLN ILE PRO ALA LEU ALA GLN ALA GLY TYR ARG VAL LEU SEQRES 7 A 344 ALA MET ASP MET LYS GLY TYR GLY GLU SER SER ALA PRO SEQRES 8 A 344 PRO GLU ILE GLU GLU TYR CYS MET GLU VAL LEU CYS LYS SEQRES 9 A 344 GLU MET VAL THR PHE LEU ASP LYS LEU GLY LEU SER GLN SEQRES 10 A 344 ALA VAL PHE ILE GLY HIS ASP TRP GLY GLY MET LEU VAL SEQRES 11 A 344 TRP TYR MET ALA LEU PHE TYR PRO GLU ARG VAL ARG ALA SEQRES 12 A 344 VAL ALA SER LEU ASN THR PRO PHE ILE PRO ALA ASN PRO SEQRES 13 A 344 ASN MET SER PRO LEU GLU SER ILE LYS ALA ASN PRO VAL SEQRES 14 A 344 PHE ASP TYR GLN LEU TYR PHE GLN GLU PRO GLY VAL ALA SEQRES 15 A 344 GLU ALA GLU LEU GLU GLN ASN LEU SER ARG THR PHE LYS SEQRES 16 A 344 SER LEU PHE ARG ALA SER ASP GLU SER VAL LEU SER MET SEQRES 17 A 344 HIS LYS VAL CYS GLU ALA GLY GLY LEU PHE VAL ASN SER SEQRES 18 A 344 PRO GLU GLU PRO SER LEU SER ARG MET VAL THR GLU GLU SEQRES 19 A 344 GLU ILE GLN PHE TYR VAL GLN GLN PHE LYS LYS SER GLY SEQRES 20 A 344 PHE ARG GLY PRO LEU ASN TRP TYR ARG ASN MET GLU ARG SEQRES 21 A 344 ASN TRP LYS TRP ALA CYS LYS SER LEU GLY ARG LYS ILE SEQRES 22 A 344 LEU ILE PRO ALA LEU MET VAL THR ALA GLU LYS ASP PHE SEQRES 23 A 344 VAL LEU VAL PRO GLN MET SER GLN HIS MET GLU ASP TRP SEQRES 24 A 344 ILE PRO HIS LEU LYS ARG GLY HIS ILE GLU ASP CYS GLY SEQRES 25 A 344 HIS TRP THR GLN MET ASP LYS PRO THR GLU VAL ASN GLN SEQRES 26 A 344 ILE LEU ILE LYS TRP LEU ASP SER ASP ALA ARG ASN PRO SEQRES 27 A 344 PRO VAL VAL SER LYS MET SEQRES 1 B 344 MET HIS HIS HIS HIS HIS HIS SER THR GLU ASN LEU TYR SEQRES 2 B 344 PHE GLN GLY SER SER THR SER CYS ASN PRO SER ASP MET SEQRES 3 B 344 SER HIS GLY TYR VAL THR VAL LYS PRO ARG VAL ARG LEU SEQRES 4 B 344 HIS PHE VAL GLU LEU GLY SER GLY PRO ALA VAL CYS LEU SEQRES 5 B 344 CYS HIS GLY PHE PRO GLU SER TRP TYR SER TRP ARG TYR SEQRES 6 B 344 GLN ILE PRO ALA LEU ALA GLN ALA GLY TYR ARG VAL LEU SEQRES 7 B 344 ALA MET ASP MET LYS GLY TYR GLY GLU SER SER ALA PRO SEQRES 8 B 344 PRO GLU ILE GLU GLU TYR CYS MET GLU VAL LEU CYS LYS SEQRES 9 B 344 GLU MET VAL THR PHE LEU ASP LYS LEU GLY LEU SER GLN SEQRES 10 B 344 ALA VAL PHE ILE GLY HIS ASP TRP GLY GLY MET LEU VAL SEQRES 11 B 344 TRP TYR MET ALA LEU PHE TYR PRO GLU ARG VAL ARG ALA SEQRES 12 B 344 VAL ALA SER LEU ASN THR PRO PHE ILE PRO ALA ASN PRO SEQRES 13 B 344 ASN MET SER PRO LEU GLU SER ILE LYS ALA ASN PRO VAL SEQRES 14 B 344 PHE ASP TYR GLN LEU TYR PHE GLN GLU PRO GLY VAL ALA SEQRES 15 B 344 GLU ALA GLU LEU GLU GLN ASN LEU SER ARG THR PHE LYS SEQRES 16 B 344 SER LEU PHE ARG ALA SER ASP GLU SER VAL LEU SER MET SEQRES 17 B 344 HIS LYS VAL CYS GLU ALA GLY GLY LEU PHE VAL ASN SER SEQRES 18 B 344 PRO GLU GLU PRO SER LEU SER ARG MET VAL THR GLU GLU SEQRES 19 B 344 GLU ILE GLN PHE TYR VAL GLN GLN PHE LYS LYS SER GLY SEQRES 20 B 344 PHE ARG GLY PRO LEU ASN TRP TYR ARG ASN MET GLU ARG SEQRES 21 B 344 ASN TRP LYS TRP ALA CYS LYS SER LEU GLY ARG LYS ILE SEQRES 22 B 344 LEU ILE PRO ALA LEU MET VAL THR ALA GLU LYS ASP PHE SEQRES 23 B 344 VAL LEU VAL PRO GLN MET SER GLN HIS MET GLU ASP TRP SEQRES 24 B 344 ILE PRO HIS LEU LYS ARG GLY HIS ILE GLU ASP CYS GLY SEQRES 25 B 344 HIS TRP THR GLN MET ASP LYS PRO THR GLU VAL ASN GLN SEQRES 26 B 344 ILE LEU ILE LYS TRP LEU ASP SER ASP ALA ARG ASN PRO SEQRES 27 B 344 PRO VAL VAL SER LYS MET HET EDO A 601 4 HET EDO A 602 4 HET EDO A 603 4 HET EDO A 604 4 HET EDO A 605 4 HET EDO A 606 4 HET PTG A 607 23 HET EDO B 601 4 HET EDO B 602 4 HET EDO B 603 4 HET EDO B 604 4 HET EDO B 605 4 HET EDO B 606 4 HET PTG B 607 23 HETNAM EDO 1,2-ETHANEDIOL HETNAM PTG (5E,14E)-11-OXOPROSTA-5,9,12,14-TETRAEN-1-OIC ACID HETSYN EDO ETHYLENE GLYCOL HETSYN PTG 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J2 FORMUL 3 EDO 12(C2 H6 O2) FORMUL 9 PTG 2(C20 H28 O3) FORMUL 17 HOH *226(H2 O) HELIX 1 AA1 ASN A 233 MET A 237 5 5 HELIX 2 AA2 SER A 270 ARG A 275 5 6 HELIX 3 AA3 TYR A 276 ALA A 284 1 9 HELIX 4 AA4 GLU A 304 TYR A 308 5 5 HELIX 5 AA5 CYS A 309 GLY A 325 1 17 HELIX 6 AA6 ASP A 335 TYR A 348 1 14 HELIX 7 AA7 SER A 370 ASN A 378 1 9 HELIX 8 AA8 PHE A 381 PHE A 387 1 7 HELIX 9 AA9 GLY A 391 ASN A 400 1 10 HELIX 10 AB1 ASN A 400 PHE A 409 1 10 HELIX 11 AB2 ALA A 411 SER A 415 5 5 HELIX 12 AB3 LYS A 421 GLY A 426 1 6 HELIX 13 AB4 THR A 443 LYS A 456 1 14 HELIX 14 AB5 PHE A 459 TRP A 465 1 7 HELIX 15 AB6 ASN A 468 LYS A 478 1 11 HELIX 16 AB7 VAL A 500 GLN A 505 5 6 HELIX 17 AB8 HIS A 506 TRP A 510 5 5 HELIX 18 AB9 TRP A 525 LYS A 530 1 6 HELIX 19 AC1 LYS A 530 ASP A 545 1 16 HELIX 20 AC2 ASN B 233 MET B 237 5 5 HELIX 21 AC3 SER B 270 ARG B 275 5 6 HELIX 22 AC4 TYR B 276 ALA B 284 1 9 HELIX 23 AC5 GLU B 304 TYR B 308 5 5 HELIX 24 AC6 CYS B 309 GLY B 325 1 17 HELIX 25 AC7 ASP B 335 TYR B 348 1 14 HELIX 26 AC8 PRO B 371 ASN B 378 1 8 HELIX 27 AC9 PHE B 381 PHE B 387 1 7 HELIX 28 AD1 GLY B 391 ASN B 400 1 10 HELIX 29 AD2 ASN B 400 PHE B 409 1 10 HELIX 30 AD3 ALA B 411 SER B 415 5 5 HELIX 31 AD4 LYS B 421 GLY B 426 1 6 HELIX 32 AD5 THR B 443 LYS B 455 1 13 HELIX 33 AD6 PHE B 459 TRP B 465 1 7 HELIX 34 AD7 ASN B 468 LYS B 478 1 11 HELIX 35 AD8 VAL B 500 GLN B 505 5 6 HELIX 36 AD9 HIS B 506 TRP B 510 5 5 HELIX 37 AE1 TRP B 525 LYS B 530 1 6 HELIX 38 AE2 LYS B 530 ASP B 545 1 16 SHEET 1 AA1 8 SER A 238 LYS A 245 0 SHEET 2 AA1 8 VAL A 248 LEU A 255 -1 O PHE A 252 N GLY A 240 SHEET 3 AA1 8 ARG A 287 MET A 291 -1 O VAL A 288 N LEU A 255 SHEET 4 AA1 8 ALA A 260 CYS A 264 1 N LEU A 263 O LEU A 289 SHEET 5 AA1 8 ALA A 329 HIS A 334 1 O VAL A 330 N CYS A 262 SHEET 6 AA1 8 VAL A 352 LEU A 358 1 O LEU A 358 N GLY A 333 SHEET 7 AA1 8 ALA A 488 ALA A 493 1 O VAL A 491 N SER A 357 SHEET 8 AA1 8 LYS A 515 ILE A 519 1 O LYS A 515 N ALA A 488 SHEET 1 AA2 8 SER B 238 LYS B 245 0 SHEET 2 AA2 8 VAL B 248 LEU B 255 -1 O VAL B 248 N LYS B 245 SHEET 3 AA2 8 ARG B 287 MET B 291 -1 O VAL B 288 N LEU B 255 SHEET 4 AA2 8 ALA B 260 CYS B 264 1 N VAL B 261 O LEU B 289 SHEET 5 AA2 8 ALA B 329 HIS B 334 1 O VAL B 330 N CYS B 262 SHEET 6 AA2 8 VAL B 352 LEU B 358 1 O LEU B 358 N GLY B 333 SHEET 7 AA2 8 ALA B 488 ALA B 493 1 O VAL B 491 N SER B 357 SHEET 8 AA2 8 LEU B 514 ILE B 519 1 O LYS B 515 N ALA B 488 CISPEP 1 PHE A 267 PRO A 268 0 -8.87 CISPEP 2 PHE B 267 PRO B 268 0 -12.46 SITE 1 AC1 7 GLU A 269 SER A 273 HIS A 334 TRP A 525 SITE 2 AC1 7 THR A 526 GLN A 527 MET A 528 SITE 1 AC2 5 MET A 293 LYS A 294 LEU A 313 GLU A 316 SITE 2 AC2 5 MET A 317 SITE 1 AC3 8 GLU A 269 SER A 270 ASP A 292 TYR A 296 SITE 2 AC3 8 GLY A 297 GLN A 453 PHE A 454 HOH A 748 SITE 1 AC4 8 PRO A 390 GLY A 391 ARG A 460 HOH A 709 SITE 2 AC4 8 HOH A 758 PRO B 302 GLU B 304 GLU B 307 SITE 1 AC5 5 ASN A 468 MET A 469 GLU A 470 ARG A 471 SITE 2 AC5 5 HOH A 751 SITE 1 AC6 4 VAL A 318 GLU A 350 ARG A 351 HOH A 712 SITE 1 AC7 11 PHE A 387 LEU A 408 SER A 412 SER A 415 SITE 2 AC7 11 MET A 419 LYS A 495 ASP A 496 PHE A 497 SITE 3 AC7 11 VAL A 498 HIS A 524 HOH A 790 SITE 1 AC8 4 MET B 293 LYS B 294 LEU B 313 GLU B 316 SITE 1 AC9 8 SER A 238 GLY A 240 PHE A 252 GLU A 254 SITE 2 AC9 8 SER B 238 GLY B 240 PHE B 252 GLU B 254 SITE 1 AD1 8 ALA B 345 LEU B 346 PRO B 349 ASP B 413 SITE 2 AD1 8 LYS B 483 LEU B 485 HOH B 716 HOH B 737 SITE 1 AD2 7 HIS B 239 HIS B 251 TRP B 271 ASP B 292 SITE 2 AD2 7 GLU B 298 GLN B 453 HOH B 763 SITE 1 AD3 3 LYS B 315 THR B 319 GLU B 494 SITE 1 AD4 3 SER B 257 GLY B 258 GLY B 285 SITE 1 AD5 10 TYR B 383 PHE B 387 SER B 412 SER B 415 SITE 2 AD5 10 MET B 419 LYS B 495 ASP B 496 PHE B 497 SITE 3 AD5 10 VAL B 498 HIS B 524 CRYST1 89.490 79.992 104.544 90.00 96.78 90.00 I 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011174 0.000000 0.001328 0.00000 SCALE2 0.000000 0.012501 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009633 0.00000